Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
|
|
|
|
|
Alternative names Return to top
Kala-azarDefinition Return to top
Leishmaniasis is a parasitic disease spread by the bite of the sandfly.Causes, incidence, and risk factors Return to top
Leishmania are tiny protozoa. Their parasitic life cycle includes the sandfly and an appropriate host. Humans are one of those hosts. Leishmania infection can cause skin disease (called cutaneous leishmaniasis).
It can affect the mucous membranes with a wide range of appearances, most frequently ulcers. It may cause skin lesions that resemble those of other diseases including cutaneous tuberculosis, syphilis, leprosy, skin cancer (basal cell carcinoma), and fungus infections.
Leishmania can also cause systemic (throughout the body) disease (called visceral leishmaniasis) with fatal complications. When introduced into the body by the bite of a sandfly, the parasite migrates to the bone marrow, spleen, and lymph nodes.
Systemic infection in children usually begins suddenly with vomiting, diarrhea, fever, and cough. In adults, fever for 2 weeks to 2 months is accompanied by nonspecific symptoms, such as fatigue, weakness, and loss of appetite. Weakness increases as the disease progresses.
The skin may become grayish, dark, dry, and flaky. The parasites damage the immune system by decreasing the numbers of disease-fighting cells so death usually results from complications (such as other infections) rather than from the disease itself. Death often occurs within 2 years.
Cases of infection by Leishmania have been reported on all the continents except Australia. In the Americas, Leishmania can be found from Mexico south into the South American continent. Leishmaniasis has been reported among some military personnel returning from the Persian Gulf. (See Travelers guide to avoiding infectious diseases.)
Symptoms Return to top
Systemic illness (visceral leishmaniasis):
Skin disease (cutaneous leishmaniasis):
Symptoms on the skin include:
Symptoms on mucous membranes include:
Signs and tests Return to top
SIGNS
TESTS
Systemic disease:
Other tests (complementary to the diagnosis)
Treatment Return to top
Antimony-containing compounds are the principal medications used to treat leishmaniasis. These include:
Other drugs that may be used include:
Plastic surgery may be required to correct disfigurement by destructive facial lesions (mucocutaneous leishmaniasis). Removal of the spleen (splenectomy) may be required in drug-resistant cases (visceral leishmaniasis).
Expectations (prognosis) Return to top
Cure rates are high with antimony compounds. Treatment should be accomplished before damage to the immune system occurs. Marked disfigurement may develop with mucocutaneous leishmaniasis.
Complications Return to top
Calling your health care provider Return to top
Contact your health care provider if you have been in an area endemic for Leishmania and may have been bitten by sandflies, and now have symptoms suggestive of leishmaniasis.
Prevention Return to top
Preventing sandfly bites is the most immediate form of protection. Insect repellent, appropriate clothing, screening of windows, and fine mesh netting around the bed (in endemic areas) will reduce exposure.
Public health measures to reduce the sandfly population and animal reservoirs are important. There are no preventive vaccines or drugs for leishmaniasis.
Update Date: 2/4/2004 Updated by: Kenneth Wener, M.D., Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA. Review provided by VeriMed Healthcare Network.
Home | Health Topics | Drug Information | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Selection Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 28 October 2004 |